TCS CEO corrects three major Nashik facts: Nida Khan was not HR head, unit not shut, no POSH complaints on record
Read More Pharma Industry News Xencor initiates Phase 1 trial of XmAb20717 for advanced solid tumors Xencor, a prominent biopharmaceutical company based in Monrovia, California, has recently dosed the first patient in a Phase… bypharmanewsdailyJuly 15, 2018
